missing translation for 'onlineSavingsMsg'
Learn More

Lonza™ Rat Neonatal Retinal Cells

Product Code. 11650441
Click to view available options
Quantity:
≥ 200,000 cells
Unit Size:
Each
This item is not returnable. View return policy

Product Code. 11650441

Brand: Lonza™ RRet508

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Cryopreserved ampule of Rat Neonatal Retinal Cells (≥200,000 cells).

  • Ready to use.
  • High-quality primary cells from Sprague Dawley rats.
  • No tissue dissection or animal handling required.
  • Increased data reproducibility.
  • Characteristic morphology and staining tests confirm tissue origin and cell type.
  • Cells are characterized by immunostaining for neuron specific class III β-tubulin (Tuj-1), specific neuronal protein gene product (PGP 9.5), ganglion cell marker, Thy1.1 and GFAP.
  • Negative for mycoplasma, bacteria, yeast and fungi.
  • Certificate of Analysis (CoA) is available for every batch
  • Applications:
    • General ophthalmic research
    • Posterior segment disease
    • Inflammation
    • Degeneration
    • Neoplasms
    • Drug delivery
    • Cell therapies
    • Toxicology and cytotoxicity
    • Gene expression
TRUSTED_SUSTAINABILITY

Specifications

Certifications/Compliance Certificate of analysis with each lot
Content And Storage Cryopreservation
Cell Type Neonatal Retinal Cells
Species Rat
Quantity ≥ 200,000 cells
Source Sprague Dawley Rat
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.